{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:36:38Z","timestamp":1789799798228,"version":"4.0.1"},"reference-count":28,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2024,1,15]]},"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1136\/ejhpharm-2023-004027","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T13:25:39Z","timestamp":1706621139000},"page":"461-467","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Combination of a propofol emulsion with alpha-2 adrenergic receptor agonists used for multimodal analgesia or sedation in intensive care units: a physicochemical stability study"],"prefix":"10.1136","volume":"32","author":[{"given":"Marine","family":"Roche","sequence":"first","affiliation":[{"name":"Pharmacy, Lille University Hospital, Lille, Nord, France"},{"name":"ULR 7365\u2014GRITA\u2014Groupe de Recherche sur les formes Injectables et les Technologies Associ\u00e9es, Lille University, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9118-8840","authenticated-orcid":false,"given":"Damien","family":"Rousseleau","sequence":"additional","affiliation":[{"name":"ULR 7365\u2014GRITA\u2014Groupe de Recherche sur les formes Injectables et les Technologies Associ\u00e9es, Lille University, Lille, France"},{"name":"Anaesthesia and Intensive Care Department, Hospital Claude Huriez, Lille University Hospital, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Danel","sequence":"additional","affiliation":[{"name":"Pharmacy, Lille University Hospital, Lille, Nord, France"},{"name":"ULR 7365\u2014GRITA\u2014Groupe de Recherche sur les formes Injectables et les Technologies Associ\u00e9es, Lille University, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9lo\u00efse","family":"Henry","sequence":"additional","affiliation":[{"name":"Pharmacy, Lille University Hospital, Lille, Nord, France"},{"name":"ULR 7365\u2014GRITA\u2014Groupe de Recherche sur les formes Injectables et les Technologies Associ\u00e9es, Lille University, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Lebuffe","sequence":"additional","affiliation":[{"name":"ULR 7365\u2014GRITA\u2014Groupe de Recherche sur les formes Injectables et les Technologies Associ\u00e9es, Lille University, Lille, France"},{"name":"Anaesthesia and Intensive Care Department, Hospital Claude Huriez, Lille University Hospital, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Odou","sequence":"additional","affiliation":[{"name":"Pharmacy, Lille University Hospital, Lille, Nord, France"},{"name":"ULR 7365\u2014GRITA\u2014Groupe de Recherche sur les formes Injectables et les Technologies Associ\u00e9es, Lille University, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4657-0282","authenticated-orcid":false,"given":"Damien","family":"Lannoy","sequence":"additional","affiliation":[{"name":"Pharmacy, Lille University Hospital, Lille, Nord, France"},{"name":"ULR 7365\u2014GRITA\u2014Groupe de Recherche sur les formes Injectables et les Technologies Associ\u00e9es, Lille University, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5257-440X","authenticated-orcid":false,"given":"Nicolas","family":"Simon","sequence":"additional","affiliation":[{"name":"Pharmacy, Lille University Hospital, Lille, Nord, France"},{"name":"ULR 7365\u2014GRITA\u2014Groupe de Recherche sur les formes Injectables et les Technologies Associ\u00e9es, Lille University, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,1,30]]},"reference":[{"key":"2025082102102338000_32.5.461.1","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020873","article-title":"POFA trial study protocol: a multicentre, double-blind, randomised, controlled clinical trial comparing opioid-free versus opioid anaesthesia on postoperative opioid-related adverse events after major or intermediate non-cardiac surgery","volume":"8","author":"Beloeil","year":"2018","journal-title":"BMJ Open"},{"key":"2025082102102338000_32.5.461.2","doi-asserted-by":"crossref","DOI":"10.1186\/s12871-022-01856-6","article-title":"The efficacy and safety of an adapted opioid-free anesthesia regimen versus conventional general anesthesia in gynecological surgery for low-resource settings: a randomized pilot study","volume":"22","author":"Tochie","year":"2022","journal-title":"BMC Anesthesiol"},{"key":"2025082102102338000_32.5.461.3","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1093\/ajhp\/zxab202","article-title":"An examination of sedation requirements and practices for mechanically ventilated critically ill patients with COVID-19","volume":"78","author":"Balakrishna","year":"2021","journal-title":"Am J Health Syst Pharm"},{"key":"2025082102102338000_32.5.461.4","first-page":"48","article-title":"Consensus for the management of analgesia, sedation and delirium in adults with COVID-19-associated acute respiratory distress syndrome","volume":"33","author":"Donato","year":"2021","journal-title":"Rev Bras Ter Intensiva"},{"key":"2025082102102338000_32.5.461.5","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06307-9"},{"key":"2025082102102338000_32.5.461.6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/0885066620951426","article-title":"Sedation, analgesia, and paralysis in COVID-19 patients in the setting of drug shortages","volume":"36","author":"Ammar","year":"2021","journal-title":"J Intensive Care Med"},{"key":"2025082102102338000_32.5.461.7","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/phar.2471","article-title":"Analgesia and sedation strategies in mechanically ventilated adults with COVID-19","volume":"40","author":"Adams","year":"2020","journal-title":"Pharmacotherapy"},{"key":"2025082102102338000_32.5.461.8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5114\/ait.2021.103542","article-title":"Systematic review of the stability and compatibility of propofol injection","volume":"53","author":"Husna","year":"2021","journal-title":"Anaesthesiol Intensive Ther"},{"key":"2025082102102338000_32.5.461.9","doi-asserted-by":"crossref","first-page":"652","DOI":"10.5507\/bp.2014.057","article-title":"Incidence of intravenous drug Incompatibilities in intensive care units","volume":"159","author":"Machotka","year":"2015","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"2025082102102338000_32.5.461.10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5935\/0103-507X.20160029","article-title":"Drug Incompatibilities in the adult intensive care unit of a university hospital","volume":"28","author":"Marsilio","year":"2016","journal-title":"Rev Bras Ter Intensiva"},{"key":"2025082102102338000_32.5.461.11","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1213\/01.ANE.0000087802.50796.FB","article-title":"Physicochemical compatibility of propofol-lidocaine mixture","volume":"97","author":"Masaki","year":"2003","journal-title":"Anesth Analg"},{"key":"2025082102102338000_32.5.461.12","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2016-001038"},{"key":"2025082102102338000_32.5.461.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2007.06.013"},{"key":"2025082102102338000_32.5.461.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2007.06.032"},{"key":"2025082102102338000_32.5.461.15","doi-asserted-by":"crossref","unstructured":"Borman P , Elder D . Chapter 5: Q2(R1) validation of analytical procedures: text and methodology. In: ICH Quality Guidelines: An implementation Guide. John Wiley & Sons, Inc, 2018: 127\u201366. doi:10.1002\/9781118971147","DOI":"10.1002\/9781118971147.ch5"},{"key":"2025082102102338000_32.5.461.16","unstructured":"Brossard D , Chedru-Legros V , Crauste-Manciet S , et al . Methodological guidelines for stability studies of hospital pharmaceutical preparations Clermont-Ferrand. Pau SFPC; GERPAC; 2013. Available: https:\/\/www.gerpac.eu\/IMG\/pdf\/guide_stabilite_anglais.pdf [Accessed 10 Mar 2019]."},{"key":"2025082102102338000_32.5.461.17","first-page":"40","article-title":"Clinical application, the use of dexmedetomidine in intensive care sedation","volume":"13","author":"Shehabi","year":"2010","journal-title":"Crit Care Shock"},{"key":"2025082102102338000_32.5.461.18","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1111\/bcp.14273","article-title":"Optimising the dose of clonidine to achieve sedation in intensive care unit patients with population pharmacokinetics","volume":"86","author":"Cloesmeijer","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"2025082102102338000_32.5.461.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-6701(13)60012-2"},{"key":"2025082102102338000_32.5.461.20","unstructured":"Queensland Health . Health guidelines for peripheral intravenous catheter (PIVC). 2013. Available: https:\/\/www.health.qld.gov. au\/__data\/assets\/pdf_file\/0025\/444490\/icare-pivc-guideline.pdf [Accessed 16 Sep 2023]."},{"key":"2025082102102338000_32.5.461.21","unstructured":"The United States Pharmacopoeial Convention . USP chapter: Globule size distribution in lipid Injectable emulsions. In: The United States Pharmacopoeia. 39th rev. Rockville, MD: US Pharmacopoeial convention, 2016: 559\u201361."},{"key":"2025082102102338000_32.5.461.22","doi-asserted-by":"crossref","unstructured":"Swarbrick J , ed. In: Zeta Potential [Internet]. In: Encyclopedia of Pharmaceutical Science and Technology. Fourth Edition. CRC Press, 2013: 3875\u201387. doi:10.1081\/E-EPT4","DOI":"10.1081\/E-EPT4-120050380"},{"key":"2025082102102338000_32.5.461.23","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13010021","article-title":"Medication safety in intravenous therapy: a compatibility study of clonidine with drugs frequently used in intensive care","volume":"13","author":"Koller","year":"2020","journal-title":"Pharmaceutics"},{"key":"2025082102102338000_32.5.461.24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-06955-w","article-title":"Niosomes: a strategy toward prevention of clinically significant drug Incompatibilities","volume":"7","author":"Mohamed","year":"2017","journal-title":"Sci Rep"},{"key":"2025082102102338000_32.5.461.25","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/jphp.12647","article-title":"Physical compatibility of total parenteral nutrition and drugs in Y-site administration to children from neonates to adolescents","volume":"69","author":"Staven","year":"2017","journal-title":"J Pharm Pharmacol"},{"key":"2025082102102338000_32.5.461.26","unstructured":"Cyril S , Anna-Maria S , Pascal B . Physical compatibility of the propofol emulsion with 33 drugs used in anaesthesiology. ESCP \u2013 GSASA Symposium on Clinical Pharmacy; 2009 Available: https:\/\/pharmacie.hug.ch\/rd\/posters\/escp09poster_cs.pdf [accessed 8 Nov 2020]."},{"key":"2025082102102338000_32.5.461.27","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/ncp.10391","article-title":"Physicochemical compatibility of dexmedetomidine with parenteral nutrition","volume":"35","author":"Campos-Baeta","year":"2020","journal-title":"Nutr Clin Pract"},{"key":"2025082102102338000_32.5.461.28","doi-asserted-by":"crossref","DOI":"10.3390\/ph12020067","article-title":"Investigations of physical compatibilities of commonly used intravenous medications with and without parenteral nutrition in pediatric cardiovascular intensive care unit patients","volume":"12","author":"Greenhill","year":"2019","journal-title":"Pharmaceuticals (Basel)"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2023-004027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T09:11:25Z","timestamp":1755767485000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2023-004027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,30]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,8,21]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1136\/ejhpharm-2023-004027"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2023-004027","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,30]]}}}